Artelo Biosciences, Inc. (ARTL) vs Curis, Inc. (CRIS)
A side-by-side comparison of Artelo Biosciences, Inc. and Curis, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARTL
Artelo Biosciences, Inc.
$3.51HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CRIS
Curis, Inc.
$0.79HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ARTL vs CRIS
growth of $100 · dividends reinvested · last 7yARTL -99.9% (-63.1%/yr)CRIS -99.9% (-61.1%/yr)CRIS compounded faster over this window
ARTL CRIS
ARTL vs CRIS: by the numbers
- •CRIS is the larger company ($2M vs $1M market cap).
- •Both run net losses; ARTL's is the smaller (0.00% vs -490.33% net margin).
Metrics side by side
Valuation
| Metric | ARTL | CRIS |
|---|---|---|
| P/S ratio | N/A | 0.36 |
| P/B ratio | 0.27 | 0.33 |
Profitability
| Metric | ARTL | CRIS |
|---|---|---|
| Gross margin | 0.00% | 99.28% |
| Operating margin | 0.00% | -348.43% |
| Net margin | 0.00% | -490.33% |
| ROE | -253.57% | -450.54% |
| ROIC | -219.36% | -567.17% |
Growth (annualized)
| Metric | ARTL | CRIS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -15.88% |
| Total return CAGR (5Y) | -64.27% | -81.06% |
Frequently asked
- How have ARTL and CRIS total returns compared?
- Over the past 5 years, ARTL delivered -64.27% and CRIS delivered -81.06% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.